A Multi-Modal Investigation of the Smoking Cessation Medication Varenicline: Dopaminergic Modulation of Reward Processing and Cognitive Control

NCT00830739 · clinicaltrials.gov ↗

COMPLETED

Status

61

Enrollment

NIH

Sponsor class

Conditions

Tobacco Use Disorder
Nicotine Dependence

Sponsor

National Institute on Drug Abuse (NIDA)